Leafcann Group Pty Ltd showcase the variety of delivery methods available and the importance of GMP certified products.

In today’s environment there is an abundance of medical cannabis products to treat a range of diseases and conditions. These products can be broken down into the delivery method of how they are administered to patients, which include but are not limited to:

There are plenty of cannabinoids with restorative properties that haven’t really been explored in the past. Here are 5 of the most promising ones for the new year.

With so much buzz surrounding CBD and THC, it’s not surprising that most people forget or don’t know that there are hundreds of other cannabinoids that are also a part of the cannabis plant. These minor compounds have been associated with plenty of benefits that set them apart from CBD and THC.

CBD has  plenty of restorative properties that have lead to its inclusion in hundreds of products. But one of the main reasons why the cannabinoid has found so much success is because it’s the easiest and cheapest compound to extract and refine, thus, garnering the most attention and scientific-based interest.

What makes an industry leader when dealing with marijuana stocks and the industry as a whole is still loosely defined. Mostly due to how young the market still is. This means that in addition to some loose definitions, the rules behind investing can often be difficult to trace. But, that’s why you’re here right? With so many different marijuana stocks to watch, spanning different areas of the market, and finding the right area to invest can prove to be more difficult than imagined.

Vape influencers, take note in the new year. On Wednesday it was announced that Facebook and Instagram will start removing posts that promote vaping, tobacco, or weapons “in the coming weeks,” according to an IG spokesperson. 

The platforms a history of banning such content. Facebook has long held the policy that advertisements for vaping, tobacco, and weapons were unacceptable on the platform. There was a workaround, however; individual users (users without business pages) could hype such products, and businesses could promote the posts, vastly expanding their audience. 

For most marijuana stocks, 2019 has turned out to be a very disappointing year. Investors could be tempted to throw in the towel altogether. But there are still some marijuana stocks with plenty of room to run.

The holiday season is now in full swing. For some folks, this means spending tons of money on gifts to reassure their loved ones that they do, in fact, still love them, in spite of all of their shortcomings. There are others, however, that would just assume jam a sharp stick in their eye than endure anything festive this time of year. There are no menorahs or Christmas trees for these people, not on your life, as they have, through a series of unfortunate events along the way, become somewhat callous to all of the lights, carols and fun that other people seem to be having.

Our patients’ lives improved in multiple ways after using CBD, including sleep, anxiety relief and hope. They began calling hemp a “miracle plant,” and we can understand why.

Chronic pain can be a very devastating diagnosis. For those of us without this condition, it’s hard to imagine what someone with chronic pain is going through. Chronic pain is usually secondary to some form of trauma, making a bad situation far worse. Imagine the worst pain you have every experienced and then try to imagine having that pain day in and day out for months or worse, for years.

Marijuana stocks have taken investors for a wild ride in 2019. When the first quarter came to a close, more than a dozen of the most popular pot stocks had gained at least 70%, and the expectation was that numerous cannabis stocks would be pushing toward profitability by year's end.

A new twins study found that marijuana use does not lower your ability to complete executive cognitive functioning.

Sorry, Tucker Carlson. New research refutes your belief that Democrats support marijuana legalization because they want to dumb-down America. A recent twin study found little support that cannabis use causes consumers to experience a decline in cognitive functions. Translation? Marijuana does not make you dumber.

When the curtain finally closes on 2019, it'll probably go down as the worst year on record for marijuana stocks. After beginning the year with more than a dozen popular pot stocks gaining in excess of 70%, a vast majority wound up losing at least half of their value, if not more, since the end of March.

If there's a light at the end of the tunnel here, it's that the longer-term outlook for the marijuana industry remains unchanged. With tens of billions of dollars being conducted in the black market each year, there's an obvious opportunity to move consumers into legal channels over time.